[Clinicobiochemical study of diagnostic value of the panel including 10 potential protein markers of prostatic cancer].
We tested diagnostic value of the panel of 10 specially selected proteins--potential markers of prostatic cancer. A double blind method and proteomic technologies were used in complex clinicobiochemical examination of 20 patients with benign and malignant tumors. The same diagnosis were obtained by clinicomorphological criteria and protein markers in 13 (65%) cases. The highest diagnostic efficacy was achieved in prostatic cancer--11 cases (79%) vs 14 by clinicomorphological criteria.
S S
SS
Shishkin
N K
NK
Dzeranov
K I
KI
Totrov
A V
AV
Kazachenko
M A
MA
Kovaleva
I Iu
IIu
Toropygin
D014408:Biomarkers, Tumor / Q000378:metabolism*; D003937:Diagnosis, Differential; D006801:Humans; D008297:Male; D009363:Neoplasm Proteins / Q000378:metabolism*; D011237:Predictive Value of Tests; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000378:metabolism*; D040901:Proteomics / Q000379:methods
D014408:Biomarkers, Tumor; D009363:Neoplasm Proteins